Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion

An immune correlates analysis of the RV144 HIV-1 vaccine trial revealed that antibody responses to the gp120 V1/V2 region correlated inversely with infection risk. The RV144 protein immunogens (A244-rp120 and MN-rgp120) were modified by an N-terminal 11-amino-acid deletion (Δ11) and addition of a he...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Alam, S. Munir, Liao, Hua-Xin, Tomaras, Georgia D., Bonsignori, Mattia, Tsao, Chun-Yen, Hwang, Kwan-Ki, Chen, Haiyan, Lloyd, Krissey E., Bowman, Cindy, Sutherland, Laura, Jeffries, Thomas L., Kozink, Daniel M., Stewart, Shelley, Anasti, Kara, Jaeger, Frederick H., Parks, Robert, Yates, Nicole L., Overman, R. Glenn, Sinangil, Faruk, Berman, Phillip W., Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Karasavva, Nicos, Rerks-Ngarm, Supachai, Kim, Jerome H., Michael, Nelson L., Zolla-Pazner, Susan, Santra, Sampa, Letvin, Norman L., Harrison, Stephen C., Haynes, Barton F.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2013
נושאים:
Vaccines and Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3554162/
https://ncbi.nlm.nih.gov/pubmed/23175357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00718-12
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים